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Abstract: The objective of this study was to investigate the influence of oral 
contraceptives on the incidence rate of alveolar osteitis (AO) following the 
surgical extraction of both impacted mandibular third molars. This 
retrospective study reviewed the clinical records of patients who presented to 
the oral surgery clinic of a university school of dentistry for the extraction of 
impacted mandibular third molars. Using a database search, all patients were 
categorized by sex, age, occurrence of AO, and whether the females were 
taking oral contraceptives at the time of surgery. The patient was considered 
positive for AO if either one or both sockets developed AO. The incidence of 
AO among women taking oral contraceptives at the time of impacted 
mandibular third molar extraction differed significantly from that in the other 
patient groups. AO occurred in 37.9% (11/29) of females taking oral 
contraceptives, while only 8.9% (16/179) of females who were not taking oral 
contraceptives at the time of extraction developed AO. The total incidence of 
AO among females was 13.0% (27/208). The total incidence of AO among the 
363 males and females presenting for mandibular third molar extractions was 
13.8%. Females who are taking oral contraceptives at the time of impacted 
mandibular third molar extraction are at a higher risk of developing AO 
following extraction. 
Key words: wisdom teeth, osteitis, oral contraceptives, infection 
The most common complication following the extraction of teeth 
is alveolar osteitis (AO).1 ‘Dry socket’ is another term used to describe 
this complication. The term dry socket was first used by Crawford in 
1896, and since that time it has been given several other names, 
including fibrinolytic alveolitis, postoperative alveolitis, localized 
osteomyelitis, fibrinolytic alveolitis, and delayed extraction wound 
healing.2 AO is a complication seen in 0.5–5% of routine extractions. It 
has been reported to occur more often following the extraction of 
impacted mandibular third molars. Studies have reported incidence 
rates as high as 37.5% following the surgical extraction of impacted 
lower third molars.3 
AO presents when the blood clot in the extraction site is 
prematurely disrupted and/or removed. This leaves the underlying 
bone unprotected and exposed to the oral environment.4 Bacterial 
contamination has been suggested as a major etiological factor.5 The 
fibrinolytic system can also cause fibrinolysis of the clot. Factors such 
as physical and mental stress, severity of the surgical procedure, and 
the type of tissue operated on can result in increased fibrinolytic 
activity.6 Other factors may also play a role in the development of AO. 
Intraoperative complications such as root fracture, alveolar bone 
fracture, or fragments from the tooth or alveolar bone remaining after 
the surgery may also result in AO. 
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There is no clear or proven aetiology for the development of AO, 
but many risk factors have been identified. These include the patient's 
sex,7 the use of oral contraceptives,8 smoking,9 patient age,10 difficulty 
of the extraction,11 surgeon's experience,12 preoperative infection,13 
and the menstrual cycle.14 and 15 Signs and symptoms of AO often 
develop within 1–3 days following surgery. The signs and symptoms 
include but are not limited to pain, sensitivity to gentle probing, foul 
taste, halitosis, localized swelling, and lymph node involvement.16 
The purpose of the present study was to investigate the 
influence of oral contraceptives on the incidence rate of AO following 
the surgical extraction of both impacted mandibular third molars. It 
was hypothesized that the incidence rate of AO would be higher among 
female patients taking oral contraceptives at the time of their surgery 
as compared to females not taking oral contraceptives. Comparisons 
were also made with all other patients presenting for the extraction of 
impacted mandibular third molars. 
Materials and methods 
A total of 363 patients aged 14–78 years presented to the oral 
surgery clinic of a university school of dentistry for the extraction of 
full bony impacted mandibular third molars. The mean ± standard 
deviation age of all patients presenting for surgery was 26.7 ± 11.16 
years. Of the total group of patients, 179 were females not taking oral 
contraceptives at the time of surgery (average age 24.5 ± 9.23 years) 
and 29 were females who reported using oral contraceptives at the 
time of surgery (average age 25.6 ± 7.18 years). All patients had both 
mandibular third molars extracted. The patients were considered 
positive for AO if they developed AO in either one or both extraction 
sockets. 
Two oral surgeons performed all extractions. Every surgery was 
for the extraction of full bony impacted mandibular third molars. The 
surgeries varied in difficulty with regard to the full bony impaction. All 
surgeries required bone removal and tooth section, which were 
performed with an electric hand-piece. All patients received the same 
care; they were given the same postoperative medications and 
instructions. Standard postoperative instructions were provided and 
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the patients were instructed to return to the clinic if they experienced 
any irregular healing, swelling, and/or pain. 
A search of the dental records database (axiUm; Exan Group, 
Coquitlam, BC, Canada) was conducted to identify patients who had 
returned to the clinic presenting with AO. A search using the following 
key words was performed in the treatment notes: “dry socket”, 
“alveolar osteitis”, “infection”, “dressing”, “pain”, and “halitosis”. All 
treatment notes that included any of the key words were reviewed to 
confirm that the patient had presented postoperatively with AO. 
“Infection” was included as a key word so that the patient's treatment 
notes could be read to determine if they had presented to the clinic 
with a postoperative infection or AO. Patient exclusion criteria included 
the use of immunosuppressive agents and/or antibiotics, an 
immunocompromised status, smoking habit, and diagnosis with a 
postoperative infection. 
Results 
The incidence of AO among females taking oral contraceptives 
at the time of impacted mandibular third molar extraction differed 
significantly from that in the other patient groups. As shown in Table 1 
and Fig. 1, AO occurred in 37.9% (11/29) of the females taking oral 
contraceptives, while only 8.9% (16/179) of females who were not 
taking oral contraceptives at the time of extraction developed AO. 
Table 1. Incidence of alveolar osteitis and use of oral contraceptives. 
 
Not taking oral 
contraceptives 
Taking oral 
contraceptives 
Total 
No alveolar 
osteitis 
163 18 181 
Alveolar osteitis 16 11 27 
Total 179 29 208 
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Fig. 1. Incidence of alveolar osteitis and use of oral contraceptives. 
The total incidence of AO among females was 13.0% (27/208). 
A similar result was found among male patients, who presented an 
incidence of AO of 14.8% (23/155). The total incidence of AO among 
the 363 males and females presenting for mandibular third molar 
extractions was 13.8% (n = 50) (Table 2, Fig. 2). 
Table 2. Incidence of alveolar osteitis in males compared to females. 
 
Male Female Total 
No alveolar osteitis 132 181 313 
Alveolar osteitis 23 27 50 
Total 155 208 363 
 
Fig. 2. Incidence of alveolar osteitis in males compared to females. 
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Pearson's χ2 test was used to compare the data. The difference 
in incidence of AO between women taking oral contraceptives at the 
time of extractions and women not taking oral contraceptives was 
found to be statistically significant (P < 0.01). Furthermore, the 
difference in incidence of AO between women taking oral 
contraceptives at the time of extractions and men was also found to be 
statistically significant (P < 0.001). 
Discussion 
The most common postoperative complication of surgical 
removal of impacted mandibular third molars is AO, due to fibrinolysis 
of the clot. The incidence of AO among women began to increase in 
the 1960s as oral contraceptives came into more widespread use. In 
1974, Schow found the incidence rate of AO to be 45% among women 
taking oral contraceptives, compared to only 17% among women not 
taking oral contraceptives.14 The higher incidence of AO can be 
attributed to the increased fibrinolysis caused by the use of oral 
contraceptives. 
The majority of the more recent studies have supported the 
conclusions reached by earlier studies. These studies have concluded 
that oral contraceptive use is a risk factor for AO following the surgical 
removal of impacted mandibular third molars. There are a few studies 
that did not find a statistical difference between women taking and not 
taking oral contraceptives. It should be noted that many of these 
studies had a relatively small sample size. 
The results from this study support previous findings; the use of 
oral contraceptives at the time of mandibular third molar extraction 
will increase the risk of developing AO following surgery. This study 
found that there was an approximately 3.5-times greater risk of 
developing AO if the female patient was taking oral contraceptives at 
the time of surgery. The incidence rates of AO in the oral contraceptive 
and non-oral contraceptive groups in the present study were similar to 
those reported in many other related studies. 
Due to the retrospective nature of this study, the results are 
reliant on the accurate postoperative diagnosis of AO by the oral 
surgeons. The description of AO is diverse and it is sometimes difficult 
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to diagnose consistently. Therefore, this study was limited because it 
was not possible to establish specific criteria for the diagnosis of AO. 
Due to the nature of third molar impactions, there is great variability 
in the extraction procedure. To overcome this problem, all surgeries 
that had complications or were deemed unusually difficult were 
excluded. Additionally, mandatory follow-up of the patients was not 
required. Therefore, it is possible that some patients developed AO but 
did not report their symptoms to the dental school. 
The majority of studies on the subject have found that oral 
contraceptive use increases the incidence rate of AO. Eshghpour et al. 
examined the menstrual cycle status of patients as a possible risk 
factor for AO. They found that the frequency of AO in women in the 
middle of their menstrual cycle was significantly greater than that in 
women during the menstrual period for both oral contraceptive users 
and non-users.15 Although there is significant evidence, more specific 
studies relating the incidence rates of AO to specific days of the female 
menstrual cycle are required to gain a better understanding of the role 
of oral contraceptives and oestrogen in the development of AO. Also, 
additional studies are needed to examine the different types of oral 
contraceptives and to determine the actual hormone levels at the time 
of surgery. 
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